TheralinkTheralink

  • Theralink
    • The Theralink platform
    • The Theralink Assay
    • Request RPPA Analyte List
    • RPPA Clinical Publications
    • RPPA Research Publications
    • RPPA Technical Publications
  • About
    • Overview
    • Oncologists
    • Mission Statement
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Board of Directors
    • Career
  • News & Media
    • Press Releases
    • Media Coverage
    • Theralink Blog
  • Biopharmas
    • Overview
    • Explore Technology
    • Explore Targets
    • Explore Pathways
    • Request Pathway Quote
    • FAQ
  • INVESTOR RELATIONS
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Investor Resources
      • FAQ
      • Contact Us
    • Corporate Governance
      • Management Team
      • Medical Advisory Board
      • Scientific Advisory Board
      • Board of Directors
  • Contact

Financial Information

Theralink   →  Financial Information

Financial Information

FINANCIAL INFORMATION

SEC Filings

  • All SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Section 16 Filings
DATE From DESCRIPTION DOCS XBRL
07/13/12 10-Q Quarterly report [Sections 13 or 15(d)]
06/28/12 8-K Current report
06/04/12 CT ORDER Confidential treatment order
01/27/12 8-K Current report
01/19/12 8-K Current report
01/17/12 10-Q Quarterly report [Sections 13 or 15(d)]
12/19/11 8-K Current report
11/01/11 CT ORDER Confidential treatment order
10/20/11 8-K Current report
10/17/11 10-Q Quarterly report [Sections 13 or 15(d)]
  • << Previous
  • 1
  • ...
  • 18
  • 19
  • 20

SEC Filings

  • All SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Section 16 Filings
Theralink Technologies intends to be a market leader in precision medicine for more effective cancer treatments

Menu

  • About
  • Investors
  • Contact
  • Privacy Policy

OUR SERVICES

  • Biopharmas
  • Oncologists
  • Media Room

Press Releases

  • Theralink® Technologies Achieves Major Milestone: California Clinical and Public Health License for its Golden, CO Laboratory
  • Theralink® Technologies Moves Closer Toward Changing the Standard of Care for All Women Newly Diagnosed with HER2+ Breast Cancer
  • Theralink® Technologies Announces Milestone Event–The Commencement of Testing on its First Patients
Copyright © 2020 Theralink. All rights reserved.